Showing results (1-10 of 441) with videos related to
Sort By:
Pageof 45
Current Opinion in Pediatrics|January 22, 2005
The biologic basis for neuroblastoma heterogeneity and risk stratificationJohn M MarisCancer Cell|December 30, 2008
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastomaJohn M MarisPediatric Blood & Cancer|November 2, 2005
Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleepWilliam G WoodsCancer Cell|January 18, 2020
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid TumorsMark Yarmarkovich, John M MarisCancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M MarisCancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M MarisCancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M MarisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M MarisCancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M MarisMolecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M MarisPageof 45